Semaglutide is a GLP-1 receptor agonist that works with metabolic pathways involved in appetite, calorie intake, and glucose-dependent insulin signaling. When prescribed as part of a clinician-guided program, it may help eligible patients manage hunger and support long-term weight-management efforts alongside appropriate nutrition and physical activity.Potential BenefitsAppetite and Satiety SupportSemaglutide affects appetite-related signaling and may help patients feel satisfied with less food, making it easier to follow an individualized nutrition plan.Reduced Calorie IntakeBy supporting feelings of fullness and reducing persistent hunger, semaglutide may help lower overall calorie intake over time.Slower Gastric EmptyingSemaglutide delays gastric emptying, which may extend post-meal fullness. Individual responses and tolerability vary.Glucose-Dependent Metabolic SupportSemaglutide stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. A licensed provider will determine whether treatment is clinically appropriate based on the patient’s health history and needs.Provider-Guided Weight ManagementTreatment is paired with medical oversight, individualized dose decisions, and ongoing evaluation rather than being offered as a stand-alone solution.